020321 – World Health Report
February 3, 2021
This report intends to give the UTD Community a snapshot of international health risks, and other issues as reported by the linked official sources from the U.S. and other countries.
Please note the revision date (mmddyy) of this report, printed on the title of the post, and go to the direct sources listed for the most up-to-date information. The information in this report may change without prior notice.
Health
- China * Communicable disease threats report, 24-30 January 2021, week 4 * Influenza A(H9N2). Update of the week. Since the previous update on 22 January 2021 and as of 28 January 2021, a human case of influenza A(H9N2) virus infection has been reported in a 52-year-old female from Xiamen, Fujian Province, China. She developed symptoms on 2 January 2021. No history of exposure to poultry or birds was reported in the WHO report. As of 13 January 2021, no cases were detected among her contacts.
- Europe * Communicable disease threats report, 24-30 January 2021, week 4 * Influenza. Update of the week. Week 03/2021 (18 January-24 January 2021). Influenza activity remained at interseasonal levels. Of 1 246 specimens tested for influenza in week 03/2021, from patients presenting with ILI or ARI symptoms to sentinel primary healthcare sites, one was positive for an influenza virus. Influenza viruses were detected sporadically from non-sentinel sources (such as hospitals, schools, primary care facilities not involved in sentinel surveillance, or nursing homes and other institutions). Both influenza type A and type B viruses were detected. There was one hospitalised laboratory-confirmed influenza case reported for week 3/2021. The influenza season in the European Region has usually been designated as having started by this point in the year, but despite widespread and regular testing for influenza reported influenza activity still remains at a very low level. The novel coronavirus disease 2019 (COVID-19) pandemic has affected healthcare-seeking behaviours, healthcare provision, and testing practices and capacities in countries and areas of the European Region, which have negatively impacted on the reporting of influenza epidemiologic and virologic data during the 2020-2021 season. Due to the COVID-19 pandemic, the influenza data we present will need to be interpreted with caution, notably in terms of seasonal patterns.
- French Antilles * Communicable disease threats report, 24-30 January 2021, week 4 * Dengue. Since the previous update with data as of 9 January 2021 and as of 24 January 2021, additional 536 cases have been reported in Guadeloupe, Saint-Martin, Saint-Barthélemy and Martinique. The following cases have been reported since the previous update: Guadeloupe: 340 additional suspected cases. Saint-Martin: 40 additional suspected cases. Saint-Barthélemy: 16 additional suspected cases. Martinique: 140 additional suspected cases, including one death.
- Italy * Communicable disease threats report, 24-30 January 2021, week 4 * Klebsiella pneumoniae ST147 producing NDM-9, and resistant to colistin and Fosfomycin. Update of the week. A prolonged outbreak of New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacterales, mostly Klebsiella pneumoniae, started in Tuscany, Italy, in November 2018 and has continued through 2021. The outbreak was mainly sustained by K. pneumoniae ST147 carrying the blaNDM-1 gene, and included in particular 323 bloodstream infections as of 3 January 2021.
Please note the revision date (mmddyy) of this report, printed on the title of the post, and go to the direct sources listed for the most up-to-date information. The information in this report may change without prior notice.
